1 duplicate copy in the archive
EFTA Document EFTA01457562
Title Matchefta-efta01457562
Case Filesd-10-EFTA01457562Dept. of JusticeEFTA Document EFTA01457562
Unknown1p
Case File
sd-10-EFTA01457562Dept. of JusticeEFTA Document EFTA01457562
Other
II May 2015 Pharmaceuticals GlaxoSmithKline Revised forecasts 'Figure 12; GSK revenue forecasts (Em); key categories/brands (Established Product detail omitted for space reasons) G8Pro FYi4/1 Pr 15E FYIGE P`I'l ?I Pel'OF FY18E FY19E Saccade,Ad...air 4.229 3.662 3.394 3,181 2,694 2,203 2,849 017 ReNar/Breo AvamysNeramyst 67 238 248 241 394 252 552 255 640 259 736 261 260 Flbrotide/Flovent 702 681 667 628 592 556 522 Ventolin 666 683 704 710 690 672
Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01457562
Pages
1
Persons
0
Integrity
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,800+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.